Call for Abstracts

  • Home
  • Call for Abstracts
EUSTM-2023 on Congress on Diagnostics, AI and ML

Abstracts Submission will be opened from 15th January, 2023 till 15th April, 2023

EUSTM cordially invites researchers/investigators & Clinicians from various disciplines & specialties working on any aspects which have direct implications for translating into immunotherapeutics, to submit Abstracts in all areas outlined under conference themes and tracks. The conference will represent a unique multidisciplinary virtual platform to discuss latest findings, advancements and approaches covering from Biology to Patient Care. Abstracts will be selected for Oral/Poster presentations. The abstracts should be submitted via online submission form.

Congress Theme A

Novel Screening & Diagnostics Methods, Tools, Techniques & Biomarkers

Novel Screening and Diagnostic Methods, Equipment, Biomarkers & Platforms

  • Analytical and synthetic methodologies
  • Validation of Biomarkers
  • Translation for Diagnostic Use
  • Medical Laboratory equipment
  • Diagnostic medical Equipment
  • Tissue based technologies (MUSE)
  • Cell based technologies (MorphoGo and Deep cell)
  • Liquid biopsy and fluid-based diagnostics

Immuno-Oncology & Multi-Omics Oncology

  • Spatial assays for translational research
  • Integrative analysis of expression and tissue data
  • Multiplexed imaging and spatial transcriptomics
  • Spatially resolved proteomics
  • Genomic and molecular Oncology testing
  • Minimal residual disease detection
  • Biomarkers for Immunotherapy
  • Cell-Free DNA in Clinical Oncology
  • Gene Mutations in Patients
  • Cancer metabolomics and biomarkers
  • Oncology companion diagnostics
  • Predictive biomarkers
  • prognostic cancer biomarkers
  • Multi-cancer early detection

At-Home & Point-of-Care Diagnostics

  • Innovation in at-home testing and self-testing
  • Advances in mobile and digital technologies for point-of-care diagnostics
  • CRISPR and synthetic biology for next-generation POCT
  • Digital and connected diagnostics for remote monitoring
  • Lab-on-Chip

Infectious Diseases: Screening & Diagnostics

  • Rapid infectious disease diagnostics and community surveillance
  • SARS-CoV-2 sequencing and variant detection
  • Multiplex respiratory virus testing
  • Host response vs. pathogen detection
  • Metagenomics-based diagnostics
  • Molecular diagnostics in resource-limited settings
  • NGS advances in clinical diagnostics

Single-Cell Multiomics & Systems Biology

  • Single-cell transcriptomics and single-cell genomics
  • Development of computational tools
  • Advances in spatial transcriptomics
  • Single-cell epigenome profiling
  • Single-cell proteomics and metabolomics
  • Systems biology and single-cell analysis
  • Single-cell immune profiling
Congress Theme B

Artificial Intelligence & Machine Learning (AI & ML)

Updates and Developments of AI/ML in Diagnostics

  • Lab med (chemistry, toxicology, micro, serology)
  • Anatomic pathology (cytology, tissue based surgical pathology)
  • Liquid biopsy
  • Radiology

Updates and Developments of AI/ML in Clinical Therapeutics

  • Oncology – solid tumour
  • Oncology – blood malignancies
  • Cardiovascular diseases
  • Infectious diseases
  • Other diseases

AI & Machine Learning in Medicine – General

Updates and Developments of AI/ML in Drug Discovery, Development & Drug Repositioning

  • Drug Discovery
  • Drug Development
  • Drug Repositioning

Updates and Developments of AI/ML in Clinical Therapeutics

Abstract Submission General Guidelines

  • The authors for accepted abstracts for oral talks will need to present oral talk (15/20 minutes) at the congress allocated slot time (pre-recorded) with the help of congress management team.
  • The authors for accepted abstracts for poster presentations will need to submit their E-Posters (pdf & 8/10 minutes video presentation)
  • All abstracts will be peer reviewed on rolling basis and presenting author will be notified once the committee decision is made.
  • Abstracts must be submitted via online submission system ONLY. Abstracts submitted via email, fax or by post will not be considered.
  • Please specify preferred presentation format.
  • The accepted abstracts authors will need to register for the congress to confirm their oral/poster presentation slots.
  • Multiple abstracts can be submitted for consideration by one person. But, only one talk per person would be allowed at the congress. Additional accepted abstracts for poster presentation, can be presented by another registered co-authors or by presenting author after paying additional administrative fees.
  • Please select congress track and theme that best describes your submission.
  • Abstract text must not exceed 450 words using 12-Regular Times New Roman font. In addition, up-to 3 tables and/or images can be submitted.
  • All presenters and co-authors must disclose any commercial interest/financial relationship.
  • Please proofread your abstract carefully before submission. Congress team will not be responsible for any typographical errors or other mistakes in the abstract.
  • By submitting an abstract, the presenting author confirms on behalf of all co-authors that all necessary ethical approvals and copyright permissions are obtained and confirms the originality of the work.
  • No further changes in the abstract will be permitted upon acceptance.
  • For technical help regarding abstract submission, please contact conference secretariat via email:[email protected]nalmedicine.org
scientist conducting gel electrophoresis biological process as part research2
female doctor wearing mask writing clipboard laboratory2 1
3d dna strands abstract background